IBD Patients Could Be Silent Carriers for Novel Coronavirus and Less Prone to its Severe Adverse Events: True or False?

por Ghavami, Shaghayegh Baradaran, Shahrokh, Shabnam, Hossein-Khannazer, Nikoo, Shpichka, Anastasia, Asadzadeh Aghdaei, Hamid, Timashev, Peter, Vosough, Massoud
Publicado 2020

Immunomodulation and Generation of Tolerogenic Dendritic Cells by Probiotic Bacteria in Patients with Inflammatory Bowel Disease

por Ghavami, Shaghayegh Baradaran, Yadegar, Abbas, Aghdaei, Hamid Asadzadeh, Sorrentino, Dario, Farmani, Maryam, Mir, Adil Shamim, Azimirad, Masoumeh, Balaii, Hedieh, Shahrokh, Shabnam, Zali, Mohammad Reza
Publicado 2020

The emerging epidemic of inflammatory bowel disease in Asia and Iran by 2035: A modeling study

por Olfatifar, Meysam, Zali, Mohammad Reza, Pourhoseingholi, Mohamad Amin, Balaii, Hedieh, Ghavami, Shaghayegh Baradaran, Ivanchuk, Maria, Ivanchuk, Pavlo, Nazari, Saeed hashemi, shahrokh, Shabnam, Sabour, Siamak, Khodakarim, Soheila, Aghdaei, Hamid Asadzadeh, Rohani, Pejman, Mehralian, Gholamhossein
Publicado 2021

Serological response to SARS‐CoV‐2 is attenuated in patients with inflammatory bowel disease and can affect immunization

por Ghavami, Shaghayegh Baradaran, Shahrokh, Shabnam, Asadzadeh Aghdaei, Hamid, Khoramjoo, Seyed Mobin, Farmani, Maryam, Kazemifard, Nesa, Parigi, Tommaso Lorenzo, Danese, Silivio, Balaii, Hedieh, Sherkat, Ghazal, Ebrahimi Daryani, Nasser, Alborzi, Foroogh, Vossoughinia, Hassan, Zali, Mohammad Reza
Publicado 2022